Literature DB >> 27234462

An observational study of the universal use of octenidine to decrease nosocomial bloodstream infections and MDR organisms.

Petra Gastmeier1, Klaus-Peter Kämpf2, Michael Behnke2, Christine Geffers2, Frank Schwab2.   

Abstract

OBJECTIVES: To investigate the effect of universal decolonization with octenidine on the incidence of ICU-acquired bloodstream infections (BSI) and MDR organisms (MDRO).
METHODS: A system-wide change in practice was performed in the ICUs of a university hospital with three campuses (eight medical ICUs and nine surgical ICUs). All ICUs had a general admission screening strategy for MRSA with subsequent isolation in the 12 month baseline period, which was stopped. After a wash-in period of 1 month, decolonization of the nose with octenidine nasal gel and octenidine wash cloths was introduced. The endpoints were ICU-acquired BSI and ICU-acquired MDRO isolates from clinical cultures. Segmented regression analysis of interrupted time series was used to assess the effect of intervention.
RESULTS: A total of 29 532 ICU patients (16 677 surgical and 12 855 medical) were included in the study. The baseline incidence density of ICU-acquired BSI was 5.1 per 1000 patient days and the baseline ICU-acquired MRSA rate was 0.97 per 1000 patient days. Whereas no significant effect on either outcome was found in surgical ICUs, we identified a significant effect on ICU-acquired BSI for the intervention in medical ICUs by means of multivariate analysis (incidence rate ratio 0.78; 95% CI 0.65-0.94). In addition, the intervention was also effective in decreasing ICU-acquired MRSA in medical ICUs (incidence rate ratio 0.58; 95% CI 0.41-0.82). No effect on ICU-acquired VRE and Gram-negative MDRO was found.
CONCLUSIONS: System change was successful by decreasing infection rates in medical ICUs and improving the management in all ICUs.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27234462     DOI: 10.1093/jac/dkw170

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  MRSA prevalence rates detected in a tertiary care hospital in Austria and successful treatment of MRSA positive patients applying a decontamination regime with octenidine.

Authors:  G Pichler; C Pux; R Babeluk; B Hermann; E Stoiser; A De Campo; A Grisold; I Zollner-Schwetz; R Krause; W Schippinger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-28       Impact factor: 3.267

2.  Antimicrobial activity of octenidine against multidrug-resistant Gram-negative pathogens.

Authors:  R Alvarez-Marin; M Aires-de-Sousa; P Nordmann; N Kieffer; L Poirel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-19       Impact factor: 3.267

3.  [Multidrug resistant bacteria in the intensive care unit : Reasonable measures for prevention].

Authors:  R Fussen; S Lemmen
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-10-20       Impact factor: 0.840

4.  Intranasal octenidine and universal antiseptic bathing reduce methicillin-resistant Staphylococcus aureus (MRSA) prevalence in extended care facilities.

Authors:  A Chow; P Y Hon; G Tin; W Zhang; B F Poh; B Ang
Journal:  Epidemiol Infect       Date:  2018-09-04       Impact factor: 4.434

5.  Prolonged outbreak of clonal MDR Pseudomonas aeruginosa on an intensive care unit: contaminated sinks and contamination of ultra-filtrate bags as possible route of transmission?

Authors:  Florian Salm; Maria Deja; Petra Gastmeier; Axel Kola; Sonja Hansen; Michael Behnke; Désirée Gruhl; Rasmus Leistner
Journal:  Antimicrob Resist Infect Control       Date:  2016-12-06       Impact factor: 4.887

6.  EFFECT of daily antiseptic body wash with octenidine on nosocomial primary bacteraemia and nosocomial multidrug-resistant organisms in intensive care units: design of a multicentre, cluster-randomised, double-blind, cross-over study.

Authors:  Anne Meißner; Dirk Hasenclever; Oana Brosteanu; Iris Freya Chaberny
Journal:  BMJ Open       Date:  2017-11-08       Impact factor: 2.692

7.  Successful control of Candida auris transmission in a German COVID-19 intensive care unit.

Authors:  Carl Hinrichs; Miriam Wiese-Posselt; Barbara Graf; Christine Geffers; Beate Weikert; Philipp Enghard; Alexander Aldejohann; Annette Schrauder; Andreas Knaust; Kai-Uwe Eckardt; Petra Gastmeier; Oliver Kurzai
Journal:  Mycoses       Date:  2022-04-24       Impact factor: 4.931

8.  Disruption of the Cytoplasmic Membrane Structure and Barrier Function Underlies the Potent Antiseptic Activity of Octenidine in Gram-Positive Bacteria.

Authors:  Nermina Malanovic; Jessica A Buttress; Djenana Vejzovic; Ayse Ön; Paulina Piller; Dagmar Kolb; Karl Lohner; Henrik Strahl
Journal:  Appl Environ Microbiol       Date:  2022-04-28       Impact factor: 5.005

9. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02       Impact factor: 1.513

10.  Co-Lateral Effect of Octenidine, Chlorhexidine and Colistin Selective Pressures on Four Enterobacterial Species: A Comparative Genomic Analysis.

Authors:  Mathilde Lescat; Mélanie Magnan; Sonia Kenmoe; Patrice Nordmann; Laurent Poirel
Journal:  Antibiotics (Basel)       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.